| While the top 10 patents holders across the world are IT companies, in India, no IT firm has patents. The list of top 10 patents holders in India comprises only pharmaceutical and bio-tech companies. |
| In India, 184 patents are held by the Council of Scientific and Industrial Research (CSIR), followed by Ranbaxy (56) and Dr Reddy's Laboratories (19). Worldwide, though, the highest number of patents is held by IBM (3,248) followed by Matsushita Electric industrial company(1,934) and Canon (1,805). |
| "In India, the software industry has a very small share of the total number of patents issued, unlike the international scenario, where the IT companies have the maximum number of patents," said Pravin Anand, a patents attorney. |
| A major deterrent for these IT companies is the Indian patents law, which does not allow software per se to be patented. |
| "Multinational IT companies have huge research facilities in India but refrain from filing for patents due to the Indian patents law. Even for inventions in their India labs, filings are made in the US or Europe," said H Subramanium, another patents attorney. |
| However, research in the pharmaceutical sector has been given a major boost after the 2005 amendments to the patents law, which allow for product patents. |
| In the US the number of pharmaceutical companies like GlaxoSmithKline and Eli Lilly that feature in the patents holders' list is only 40. |
| "Pharmaceutical majors feature low on the list of patents holders as the pace for research in the sector is much slower than in the IT sector," added Subramanium. |
| "The cost of researching new molecules is much higher than the cost of discovering new algorithms. While it makes commercial sense to get patents for newer versions of a software, it is not so for newer molecules," said an industry expert. |
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
